Evolent Health Affirms FY2026 Sales Guidance of $2.600B-$2.700B vs $2.626B Est
Benzinga Newsdesk 1 day ago
NewsGuidance
Evolent Health (NYSE:EVH) affirms FY2026 sales outlook from $2.600 billion-$2.700 billion to $2.600 billion-$2.700 billion vs $2.626 billion estimate.
Evolent Health (NYSE:EVH) affirms FY2026 sales outlook from $2.600 billion-$2.700 billion to $2.600 billion-$2.700 billion vs $2.626 billion estimate.